• If you are wondering whether Colgate-Palmolive stock still offers solid value at around US$86.33, it helps to look past the brand and focus on what the current price actually reflects.
• Over shorter periods the stock has moved only modestly, with returns of 0.8% over the last 7 days, 1.4% over the last 30 days and 11.1% year to date, while the 1 year return stands at a 2.7% decline and the 3 and 5 year returns are 14.9% and 17.9% respectively.
• Recent coverage has focused on Colgate-Palmolive as a large, established household products stock, which often draws interest when investors reassess defensive sectors or brand strength. This context helps explain why smaller price moves can still attract attention, as investors compare the stock to alternatives in the same sector and broader market.
• Colgate-Palmolive currently has a valuation score of 2 out of 6. This means it screens as undervalued on 2 of 6 checks. The rest of this article will look at what different valuation approaches say about that score and will point to an even richer way of thinking about valuation at the end.

Colgate-Palmolive scores just 2/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Colgate-Palmolive Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting future cash flows and discounting them back to today, using the idea that money available now is worth more than the same amount later.

For Colgate-Palmolive, the model starts with last twelve months Free Cash Flow (FCF) of about $3.7b and then uses a 2 Stage Free Cash Flow to Equity approach. Analysts provide FCF estimates for the next few years, such as $2.7b in 2026 and $3.4b in 2027. Simply Wall St then extrapolates further out, with projected FCF of $4.0b by 2030. All of these future cash flows are discounted back to today based on the model’s required return assumptions.

This process results in an estimated intrinsic value of $120.03 per share. Compared with the recent share price of about $86.33, the DCF suggests the stock trades at a 28.1% discount, which indicates that Colgate-Palmolive screens as undervalued on this measure.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Colgate-Palmolive is undervalued by 28.1%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: Colgate-Palmolive Price vs Earnings

For a profitable company like Colgate-Palmolive, the P/E ratio is a useful way to relate what you pay for the stock to the earnings the business is currently generating. Investors usually expect higher growth or lower risk to justify a higher P/E, while slower growth or higher risk often lines up with a lower, more conservative P/E range.

Colgate-Palmolive currently trades on a P/E of 33.08x. That sits above both the Household Products industry average P/E of 17.39x and a peer group average of 20.86x, so on simple comparisons the stock looks relatively expensive. Simply Wall St adds another lens through its proprietary Fair Ratio, which estimates what a more tailored P/E might be, given factors like earnings growth, profit margins, industry, market cap and specific risks.

This Fair Ratio for Colgate-Palmolive is 23.72x, which is designed to be more precise than broad peer or industry comparisons because it adjusts for the company’s own characteristics rather than assuming all stocks in the group deserve similar multiples. Compared with the current P/E of 33.08x, the Fair Ratio points to the stock trading above that modelled range, so on this measure it screens as overvalued.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Colgate-Palmolive Narrative

Earlier it was mentioned that there is an even better way to understand valuation. This is where Narratives come in, giving you a simple story that links your view of Colgate-Palmolive to a financial forecast and then to a fair value. Narratives let you set assumptions for future revenue, earnings and margins, compare the resulting Fair Value with today’s price on the Simply Wall St Community page, and see that story update automatically when new earnings or news arrive. This helps explain why one investor might align with the more optimistic US$105 target, another with the more cautious US$85 view, and how you can quickly see which version of the story you find more reasonable.

Do you think there's more to the story for Colgate-Palmolive? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.